Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Martin

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Clinical Genitourinary Cancer|August 29, 2024
Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and NivolumabMoshe C Ornstein, Laeth George, Wei Wei, et al.
The Medical Journal of Australia|May 27, 2025
Remote patient monitoring for managing acute COVID-19, and mortality and hospital use in Sydney, New South Wales, 2021-22: a retrospective observational cohort studyMyong Gyu Kim, Phuong Thao Phan, Cambell McMaster, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 9, 2019
Does recall period matter? Comparing PROMIS<sup>®</sup> physical function with no recall, 24-hr recall, and 7-day recallDavid M Condon, Robert Chapman, Sara Shaunfield, et al.
BMJ Open|December 31, 2025
Digital support for chronic dyspnoea management in primary care: protocol for the BREATHE (Breathlessness Rapid Evaluation and Therapy) cluster randomised controlled trialAllison Martin, Anthony Paulo Sunjaya, Katrina Giskes, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 15, 2022
Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic coughPeter V Dicpinigaitis, Surinder S Birring, Michael Blaiss, et al.
Lung|July 27, 2022
Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined SubgroupsJaclyn A Smith, Surinder S Birring, Peter V Dicpinigaitis, et al.
Hepatology (Baltimore, Md.)|January 14, 2025
Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multicenter prospective cohort studyEdison Xu, Parissa Tabrizian, Julio Gutierrez, et al.
Targeted Oncology|April 7, 2018
Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials: Focus on Efficacy, Safety, and Response to Subsequent TherapiesPedro C Barata, Dhrmesh Gopalakrishnan, Vadim S Koshkin, et al.
British Journal of Cancer|May 26, 2018
The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinomaPedro Coelho Barata, Alfonso Gomez De Liano, Prateek Mendiratta, et al.
Journal for Immunotherapy of Cancer|January 31, 2024
Effects of antineoplastic and immunomodulating agents on postvaccination SARS-CoV-2 breakthrough infections, antibody response, and serological cytokine profileJacob New, Jason Cham, Lana Smith, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Clinical Genitourinary Cancer|August 29, 2024
Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and NivolumabMoshe C Ornstein, Laeth George, Wei Wei, et al.
The Medical Journal of Australia|May 27, 2025
Remote patient monitoring for managing acute COVID-19, and mortality and hospital use in Sydney, New South Wales, 2021-22: a retrospective observational cohort studyMyong Gyu Kim, Phuong Thao Phan, Cambell McMaster, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 9, 2019
Does recall period matter? Comparing PROMIS<sup>®</sup> physical function with no recall, 24-hr recall, and 7-day recallDavid M Condon, Robert Chapman, Sara Shaunfield, et al.
BMJ Open|December 31, 2025
Digital support for chronic dyspnoea management in primary care: protocol for the BREATHE (Breathlessness Rapid Evaluation and Therapy) cluster randomised controlled trialAllison Martin, Anthony Paulo Sunjaya, Katrina Giskes, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 15, 2022
Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic coughPeter V Dicpinigaitis, Surinder S Birring, Michael Blaiss, et al.
Lung|July 27, 2022
Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined SubgroupsJaclyn A Smith, Surinder S Birring, Peter V Dicpinigaitis, et al.
Hepatology (Baltimore, Md.)|January 14, 2025
Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multicenter prospective cohort studyEdison Xu, Parissa Tabrizian, Julio Gutierrez, et al.
Targeted Oncology|April 7, 2018
Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials: Focus on Efficacy, Safety, and Response to Subsequent TherapiesPedro C Barata, Dhrmesh Gopalakrishnan, Vadim S Koshkin, et al.
British Journal of Cancer|May 26, 2018
The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinomaPedro Coelho Barata, Alfonso Gomez De Liano, Prateek Mendiratta, et al.
Journal for Immunotherapy of Cancer|January 31, 2024
Effects of antineoplastic and immunomodulating agents on postvaccination SARS-CoV-2 breakthrough infections, antibody response, and serological cytokine profileJacob New, Jason Cham, Lana Smith, et al.
Pageof 12